Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Breast cancer diagnosis and treatment wait times in specialized diagnostic units compared with usual care: a population-based study.
Current oncology (Toronto, Ont.)·2020
Baseline staging imaging for distant metastasis in women with stages I, II, and III breast cancer.
Current oncology (Toronto, Ont.)·2020
Cost-utility analysis of 21-gene assay for node-positive early breast cancer.
Current oncology (Toronto, Ont.)·2019
Impact of a novel prioritization framework on clinician-led oncology drug submissions.
Current oncology (Toronto, Ont.)·2019
The brain fatigue syndrome: a cross-diagnostic phenomenon.
Frontiers in human neuroscience·2026
Role of Miro1 in Mitochondrial Dysfunction and Neurodegeneration in Huntington's Disease.
Current neurovascular research·2026
Juvenile Huntington Disease With Cerebellar-Predominant Atrophy Identified by Genome Sequencing.
Annals of clinical and translational neurology·2026